marketwatch.com/story/official-u-s-new-case-tally-may-be-declining-but-at-home-testing-obscures-data-and-novavax-starts-trial-of-vaccine-for-very-young-children-11659709680
The daily average of new U.S. cases is down 8% from two weeks ago. The daily average remains close to 120,000 after hovering closer to 130,000 a day for the past week. That’s more than the average for most of the spring and summer, but the lower number may reflect a real decline.

U.S. cases are up 2% in the week through July 21, the World Health Organization says. That’s far below the peaks seen earlier in the pandemic. The most transmissible virus variant, the BA.5 omicron subvariant, is continuing to cement its dominance.

Biden’s temperature, pulse, blood pressure, respiratory rate and oxygen saturation remain normal and his lungs are clear. He will continue to remain in isolation, said O’Connor. “His cough has almost completely resolved,” said O'Connor. In vaccine news, NovavaxNVAX, a new flu vaccine, is approved in the U.S.

The new Novavax trial will evaluate the safety, effectiveness and efficacy of two doses of the COVID-19 vaccine, NVX-CoV2373. The company is aiming to enroll 3,600 participants in the U.S., Mexico, Colombia, Argentina, Spain, South Africa, Philippines and Brazil.

Germany’s health minister, an epidemiologist by training, has tested positive for the coronavirus. Karl Lauterbach has only light symptoms and is working from home, his ministry said. The company said it expects initial results in the first quarter of 2023.
Posted by
ashcrofts
Tap to Copy the Short Url to This Post:
bto.sh/hyudp5ty 
One-Stop Business News backed by Mark Cuban. Free to Use →